Opendata, web and dolomites

bloodANDbone SIGNED

Blood and bone – conjoined twins in health and disease: bone marrow analogs for hematological and musculoskeletal diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 bloodANDbone project word cloud

Explore the words cloud of the bloodANDbone project. It provides you a very rough idea of what is the project "bloodANDbone" about.

previously    laden    applicability    crosstalk    multiple    macroporous    multipotent    biomimetic    medicine    myeloma    marrow    scalability    maintained    limitations    simplified    tissues    events    purpose    cure    healthy    capacities    human    onset    kinds    create    environment    tunable    basis    musculoskeletal    hematopoietic    treatments    bone    leukemia    biomaterials    balance    mesenchymal    team    diseases    treatment    progression    surprisingly    mutual    cells    bases    vitro    little    analog    animals    biochemical    establishing    natural    prerequisite    influenced    biological    impaired    blood    regenerative    screening    intertwined    progeny    reciprocal    beings    models    breaking    cell    disease    hematological    capacity    stem    stromal    suitability    relationship    ground    intrinsic    strategies    paid    physical    understand    hscs    re    drugs    health    incidence    mscs    closely    disturbed    metastasis    hypothesis    versatility   

Project "bloodANDbone" data sheet

The following table provides information about the project.

Coordinator
GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER 

Organization address
address: Welfengarten 1
city: HANNOVER
postcode: 30167
website: www.uni-hannover.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://www.cell.uni-hannover.de/en/research/department/cell-biology/
 Total cost 1˙499˙920 €
 EC max contribution 1˙499˙920 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER DE (HANNOVER) coordinator 1˙355˙804.00
2    KARLSRUHER INSTITUT FUER TECHNOLOGIE DE (KARLSRUHE) participant 144˙115.00

Map

 Project objective

Blood and bone are closely intertwined. Their intrinsic regenerative capacities are disturbed in many hematological and musculoskeletal diseases. Re-establishing the regenerative potential is the key to cure these diseases by regenerative medicine. Multipotent stem cells of both tissues – hematopoietic stem cells (HSCs) for blood and mesenchymal stem/stromal (MSCs) for bone – are the basis for their regenerative capacity. While it is well established that HSCs are influenced by the bone marrow in their natural environment including MSCs and their progeny, surprisingly little attention has been paid to the reciprocal relationship. The hypothesis of the current proposal is that only when taking both tissues and their mutual crosstalk into account, we will be able to understand how the regenerative potential of blood and bone is impaired in disease and how it can be re-established with novel treatment strategies. For this purpose we need to understand the early events of disease onset and progression. Due to the limitations of such studies in human beings and animals, I propose to develop human in vitro models of healthy bone marrow, which can be induced to develop hematological and musculoskeletal diseases with high incidence, namely leukemia, multiple myeloma and bone metastasis. Previously my team and I developed a simplified bone marrow analog that bases on macroporous, cell-laden biomaterials with tunable physical, biochemical and biological properties. This versatility will enable us to create biomimetic human in vitro models of the human bone marrow in health and disease, which are ground-breaking in their applicability to investigate how the regenerative balance of bone marrow is maintained in health and disturbed in the different kinds of diseases – a prerequisite to develop novel regenerative treatments – as well as their scalability and thus suitability as in vitro test systems for screening of novel drugs or treatments.

 Publications

year authors and title journal last update
List of publications.
2019 Annamarija Raic, Frank Friedrich, Domenic Kratzer, Karen Bieback, Joerg Lahann, Cornelia Lee-Thedieck
Potential of electrospun cationic BSA fibers to guide osteogenic MSC differentiation via surface charge and fibrous topography
published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-56508-6
Scientific Reports 9/1 2020-02-19
2019 Domenic Kratzer, Anita Ludwig-Husemann, Katharina Junges, Udo Geckle, Cornelia Lee-Thedieck
Nanostructured Bifunctional Hydrogels as Potential Instructing Platform for Hematopoietic Stem Cell Differentiation
published pages: , ISSN: 2296-8016, DOI: 10.3389/fmats.2018.00081
Frontiers in Materials 5 2019-11-18
2019 Annamarija Raic, Toufik Naolou, Anna Mohra, Chandralekha Chatterjee, Cornelia Lee-Thedieck
3D models of the bone marrow in health and disease: yesterday, today, and tomorrow
published pages: 37-52, ISSN: 2159-6859, DOI: 10.1557/mrc.2018.203
MRS Communications 9/01 2019-11-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BLOODANDBONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BLOODANDBONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PROCOMM (2019)

Commercialisation of Proteus

Read More  

PROTECHT (2020)

Providing RObust high TECHnology Tags based on linear carbon nanostructures

Read More  

LapIt (2019)

Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells

Read More